Table 3.
3DE Parameters Before and at Each Follow-Up Point During Chemotherapy
| T0 | T1 | T2 | T3 | |
|---|---|---|---|---|
| RVEDV, ml | 58.5 ± 7.7 | 60.2 ± 7.7 | 64.2 ± 7.0∗† | 66.0 ± 6.6∗† |
| RVESV, ml | 27.8 ± 4.2 | 28.9 ± 4.3 | 31.3 ± 4.2∗† | 34.1 ± 3.7∗†‡ |
| RVEF, % | 54.0 ± 2.8 | 53.6 ± 2.9 | 52.8 ± 3.1 | 49.8 ± 2.4∗†‡ |
| RVLFS, % | −27.3 ± 3.1 | −25.4 ± 3.3 | −24.2 ± 2.6∗ | −21.9 ± 2.8∗†‡ |
| RVLSS, % | −26.1 ± 2.5 | −25.6 ± 2.9 | −24.7 ± 2.9 | −22.9 ± 2.7∗† |
| LVEDV, ml | 77.6 ± 10.0 | 78.2 ± 11.2 | 79.4 ± 9.7 | 80.4 ± 12.0 |
| LVESV, ml | 30.3 ± 7.6 | 31.5 ± 6.9 | 32.0 ± 6.4 | 33.2 ± 8.0 |
| LVEF, % | 62.1 ± 5.7 | 61.5 ± 5.1 | 60.5 ± 6.2 | 59.3 ± 5.9 |
| LVGLS, % | −24.2 ± 3.6 | −22.3 ± 4.0 | −20.5 ± 3.3∗ | −19.1 ± 4.2∗† |
| LVGCS, % | −26.6 ± 5.3 | −25.7 ± 4.9 | −24.9 ± 4.6 | −23.7 ± 5.6∗ |
Values are mean ± SD.
LVEDV = left ventricular end-diastolic volume; LVEF = left ventricular ejection fraction; LVESV = left ventricular end-systolic volume; LVGCS = left ventricular global circumferential strain; LVGLS = left ventricular global longitudinal strain; RVEDV = right ventricular end-diastolic volume; RVEF = right ventricular ejection fraction; RVESV = right ventricular end-systolic volume; RVLFS = right ventricular longitudinal free-wall strain; RVLSS = right ventricular longitudinal septal strain; other abbreviations are as in Table 2.
∗
Compared with T0, p < 0.05.
†
Compared with T1, p < 0.05.
‡
Compared with T2, p < 0.05.